Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
NCT05408624 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-03-21
Summary
Pelvic inflammatory diseases (PID) require antibiotic treatment. Among PID, the investigators distinguish: pelvi-peritonitis and pelvic collections such as Douglas abscess and/or tubo-ovarian abscess (TOA).
Recent recommendations published in December 2018 by the National College of French Gynecologists and Obstetricians (CNGOF) suggest that it is preferable to drain TOA when their size is greater than 3-4 cm. Ultrasound-guided transvaginal drainage is recommended as first-line treatment because of its ease of performance and its effectiveness. In the literature, many authors have demonstrated the feasibility and efficacy of transvaginal drainage associated with antibiotics in the treatment of TOA. Since ultrasound-guided transvaginal drainage is a less invasive alternative therapeutic procedure than laparoscopy for the drainage of TOA, it would be compatible with outpatient management. This mode of management can be carried out in a dedicated outpatient or functional exploration room with the help of a nurse but without an anesthetic team present. This gesture is simple and short-lived. In addition, the antibiotics used have pharmacological properties allowing oral intake from their initiation.
The investigators have proposed a new service protocol to treat TOA in this outpatient mode. The investigators therefore wish to analyze this new protocol from these three angles: 1/ the feasibility of this care, 2/ the quality of life of the patients through questionnaires given throughout the care and 3/ an evaluation of the 'efficiency.
Conditions
- Abscess
- Pelvic Inflammatory Disease
- Pelvic Infection
Interventions
- PROCEDURE
-
ultrasound transvaginal drainage
Ultrasound-guided transvaginal drainage of TOA by a puncture under simple sedation or analgesia with/or under general anesthesia
- PROCEDURE
-
laparoscopy
Laparoscopy for drainage of TOA under general anesthesia
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-15
- Primary Completion
- 2024-06-30
- Completion
- 2024-12-01
Countries
- France
Study Locations
More Related Trials
-
Peri-appendiceal Abscess and Phlegmon in Acute Complicated Appendicitis Patients
NCT06490185 ·Status: NOT_YET_RECRUITING
-
Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis
NCT03310606 ·Status: UNKNOWN ·Phase: NA
-
Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
NCT00783419 ·Status: COMPLETED
-
Prevalence of Carriage of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteria in Preterm Premature Rupture of Membranes : A French Multicenter Cohort Study
NCT07200999 ·Status: NOT_YET_RECRUITING
-
Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis
NCT02447224 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments
NCT01703299 ·Status: COMPLETED
-
Multicentre Observational Study on Community Acquired Intraabdominal Infections Management
NCT03544203 ·Status: COMPLETED
-
Evaluation of Laparoscopic Peritoneal Lavage for Perforated Diverticulitis: A National Registry - Based Study
NCT05893095 ·Status: COMPLETED
-
Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP
NCT02364284 ·Status: COMPLETED
-
MICROBIOLOGY OF CEREBRAL ABSCESSES
NCT04018742 ·Status: UNKNOWN
-
CABI: Antibiotic Duration for Complicated Intra-ABdominal Infection
NCT03265834 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Etiology of Intra-Abdominal Infections
NCT00244088 ·Status: COMPLETED
-
EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.
NCT05148702 ·Status: RECRUITING ·Phase: PHASE3
-
Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
NCT00860587 ·Status: UNKNOWN
-
Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
NCT02127450 ·Status: COMPLETED
-
Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis
NCT03179384 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection
NCT04927312 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence of ESBL and CPE in French Nursing Homes
NCT03401242 ·Status: COMPLETED
-
Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital.
NCT02631226 ·Status: UNKNOWN
-
Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous
NCT04947748 ·Status: UNKNOWN ·Phase: NA
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
NCT01764490 ·Status: COMPLETED
-
Uterine Microbiome in Women with Repeated Implantation Failure and Normal Fertile Women
NCT03405883 ·Status: COMPLETED
-
Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus
NCT02547272 ·Status: COMPLETED
-
Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study
NCT05521139 ·Status: COMPLETED
-
Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections
NCT01155739 ·Status: COMPLETED